Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 3 | 9 |
| List of Tables | 6 | 3 |
| List of Figures | 9 | 3 |
| Clinical Trial Recruitment in CVD - Introduction | 12 | 2 |
| GBI Research Report Guidance | 13 | 1 |
| Clinical Trial Recruitment in CVD - Overview | 14 | 10 |
| Clinical Trials Share by Therapeutic Area, 2005-2010 | 14 | 7 |
| Clinical Trials by Major Pharmaceutical Companies, 2005-2010 | 21 | 1 |
| Clinical Trial and Patient Recruitment for Major Indications, 2000-2009 | 22 | 2 |
| Clinical Trials and Patient Recruitment for Hypertension | 24 | 14 |
| Introduction | 24 | 1 |
| Number of Clinical Trials for Hypertension | 25 | 1 |
| Number of Clinical Trials by Phase | 25 | 1 |
| Number of Clinical Trials for Hypertension by Major Sponsors | 26 | 1 |
| Number of Clinical Trials for Hypertension by Geography | 27 | 1 |
| Number of Clinical Trials for Hypertension by Year | 28 | 1 |
| Prevalence Population for Hypertension (2010-2017) | 29 | 1 |
| Brazil | 29 | 1 |
| India | 30 | 1 |
| China | 31 | 1 |
| Patient Recruitment for Hypertension | 32 | 1 |
| Number of Patients Recruited by Phase of Clinical Trial | 32 | 1 |
| Number of Patients Recruited by Major Sponsors | 33 | 1 |
| Number of Patients Recruited by Geography | 34 | 1 |
| Number of Patients Recruited per Year | 35 | 1 |
| Average Number of Patients Recruited Per Trial | 36 | 1 |
| Average Number of Patients Recruited per Trial by Stage of Development | 36 | 1 |
| Average Number of Patients Recruited per Trial per Year | 37 | 1 |
| Clinical Trials and Patient Recruitment for Atherosclerosis | 38 | 14 |
| Introduction | 38 | 1 |
| Number of Clinical Trials for Atherosclerosis | 38 | 1 |
| Number of Clinical Trials by Phase | 38 | 2 |
| Number of Clinical Trials by Sponsor | 40 | 1 |
| Number of Clinical Trials by Geography | 41 | 1 |
| Number of Clinical Trials by Year | 42 | 1 |
| Prevalence Population for Atherosclerosis (2010-2017) | 43 | 1 |
| Brazil | 43 | 1 |
| India | 44 | 1 |
| China | 45 | 1 |
| Patient Recruitment for Atherosclerosis | 46 | 1 |
| Number of Patients Recruited By Phase of Clinical Trial | 46 | 1 |
| Number of Patients Recruited by Sponsor | 47 | 1 |
| Number of Patients Recruited by Geography | 48 | 1 |
| Number of Patients Recruited per Year | 49 | 1 |
| Average Number of Patients Recruited per Trial | 50 | 1 |
| Average Number of Patients Recruited per Trial by Stage of Development | 50 | 1 |
| Average Number of Patients Recruited per Trial per Year | 51 | 1 |
| Clinical Trials and Patient Recruitment for Dyslipidemia | 52 | 14 |
| Introduction | 52 | 1 |
| Number of Clinical Trials for Dyslipidemia | 52 | 1 |
| Number of Clinical Trials by Phase | 52 | 2 |
| Number of Clinical Trials by Major Sponsor | 54 | 1 |
| Number of Clinical Trials by Geography | 55 | 1 |
| Number of Clinical Trials by Year | 56 | 1 |
| Prevalence Population for Dyslipidemia (2010-2017) | 57 | 1 |
| Brazil | 57 | 1 |
| India | 58 | 1 |
| China | 59 | 1 |
| Patient Recruitment for Dyslipidemia | 60 | 1 |
| Number of Patients Recruited by Phase of Clinical Trial | 60 | 1 |
| Number of Patients Recruited by Major Sponsors | 61 | 1 |
| Number of Patients Recruited by Geography | 62 | 1 |
| Number of Patients Recruited per Year | 63 | 1 |
| Average Number of Patients Recruited per Trial | 64 | 1 |
| Average Number of Patients Recruited per Trial by Stage of Development | 64 | 1 |
| Average Number of Patients Recruited per Trial per Year | 65 | 1 |
| Clinical Trials and Patient Recruitment for Atrial Fibrillation | 66 | 14 |
| Introduction | 66 | 1 |
| Number of Clinical Trials for Atrial Fibrillation | 67 | 1 |
| Number of Clinical Trials by Phase | 67 | 1 |
| Number of Clinical Trials by Major Sponsors | 68 | 1 |
| Number of Clinical Trials by Geography | 69 | 1 |
| Number of Clinical Trials by Year | 70 | 1 |
| Prevalence Population for Atrial Fibrillation (2010-2017) | 71 | 1 |
| Brazil | 71 | 1 |
| India | 72 | 1 |
| China | 73 | 1 |
| Patient Recruitment for Atrial Fibrillation | 74 | 1 |
| Number of Patients Recruited by Phase of Clinical Trial | 74 | 1 |
| Number of Patients Recruited by Major Sponsors | 75 | 1 |
| Number of Patients Recruited by Geography | 76 | 1 |
| Number of Patients Recruited per Year | 77 | 1 |
| Average Number of Patients Recruited Per Trial | 78 | 1 |
| Average Number of Patients Recruited per Trial by Stage of Development | 78 | 1 |
| Average Number of Patients Recruited per Trial per Year | 79 | 1 |
| Clinical Trials and Patient Recruitment for Venous Thromboembolism | 80 | 14 |
| Introduction | 80 | 1 |
| Number of Clinical Trials for Venous Thromboembolism | 80 | 1 |
| Number of Clinical Trials by Phase | 80 | 2 |
| Number of Clinical Trials by Sponsor | 82 | 1 |
| Number of Clinical Trials by Geography | 83 | 1 |
| Number of Clinical Trials by Year | 84 | 1 |
| Prevalence Population for Venous Thromboembolism (2010-2017) | 85 | 1 |
| Brazil | 85 | 1 |
| India | 86 | 1 |
| China | 87 | 1 |
| Patient Recruitment for Venous Thromboembolism | 88 | 1 |
| Number of Patients Recruited By Phase of Clinical Trial | 88 | 1 |
| Number of Patients Recruited by Major Sponsors | 89 | 1 |
| Number of Patients Recruited By Geography | 90 | 1 |
| Number of Patients Recruited Per Year | 91 | 1 |
| Average Number of Patients Recruited per Trial | 92 | 1 |
| Average Number of Patients Recruited per Trial by Stage of Development | 92 | 1 |
| Average Number of Patients Recruited per Trial per Year | 93 | 1 |
| Appendix | 94 | 5 |
| Market Definitions | 94 | 1 |
| Abbreviations | 94 | 1 |
| Research Methodology | 95 | 2 |
| Clinical Trials Overview | 95 | 1 |
| Number of Clinical Trials | 95 | 1 |
| Patient Recruitment Status | 96 | 1 |
| Prevalence of Disease in India, China and Brazil (2010-2017) | 96 | 1 |
| Coverage | 96 | 1 |
| Secondary Research | 96 | 1 |
| Primary Research | 97 | 1 |
| Expert Panel Validation | 97 | 1 |
| Contact Us | 97 | 1 |
| Disclaimer | 97 | 1 |
| Sources | 98 | 1 |